Clinical Trial Update: Airflow Limitation in Cardiac Diseases in Europe

View source ↗

Summary

GlaxoSmithKline-sponsored European trial evaluating airflow limitation in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED